CN116235846B - Organ perfusion control method, system and device - Google Patents
Organ perfusion control method, system and device Download PDFInfo
- Publication number
- CN116235846B CN116235846B CN202310171998.0A CN202310171998A CN116235846B CN 116235846 B CN116235846 B CN 116235846B CN 202310171998 A CN202310171998 A CN 202310171998A CN 116235846 B CN116235846 B CN 116235846B
- Authority
- CN
- China
- Prior art keywords
- pressure
- perfusion
- flow
- real
- organ
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000010412 perfusion Effects 0.000 title claims abstract description 82
- 210000000056 organ Anatomy 0.000 title claims abstract description 50
- 238000000034 method Methods 0.000 title claims abstract description 27
- 238000013528 artificial neural network Methods 0.000 claims description 20
- 230000000541 pulsatile effect Effects 0.000 claims description 14
- 230000010349 pulsation Effects 0.000 claims description 12
- 210000003462 vein Anatomy 0.000 claims description 9
- 210000001367 artery Anatomy 0.000 claims description 8
- 230000008859 change Effects 0.000 claims description 6
- 238000012549 training Methods 0.000 claims description 6
- 230000006870 function Effects 0.000 claims description 5
- 230000036770 blood supply Effects 0.000 claims description 4
- 230000008878 coupling Effects 0.000 claims description 4
- 238000010168 coupling process Methods 0.000 claims description 4
- 238000005859 coupling reaction Methods 0.000 claims description 4
- 230000000737 periodic effect Effects 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims 3
- 230000006641 stabilisation Effects 0.000 claims 3
- 238000011105 stabilization Methods 0.000 claims 3
- 238000004891 communication Methods 0.000 claims 2
- 230000001276 controlling effect Effects 0.000 claims 1
- 238000001802 infusion Methods 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000002194 synthesizing effect Effects 0.000 claims 1
- 210000004185 liver Anatomy 0.000 abstract description 7
- 206010018910 Haemolysis Diseases 0.000 abstract description 4
- 230000008588 hemolysis Effects 0.000 abstract description 4
- 238000004321 preservation Methods 0.000 abstract description 4
- 230000008439 repair process Effects 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 230000008901 benefit Effects 0.000 description 6
- 238000010586 diagram Methods 0.000 description 6
- 210000002767 hepatic artery Anatomy 0.000 description 6
- 210000003240 portal vein Anatomy 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 210000001631 vena cava inferior Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 3
- 238000002054 transplantation Methods 0.000 description 3
- 238000000502 dialysis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 206010063837 Reperfusion injury Diseases 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000000082 organ preservation Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
- A01N1/142—Apparatus
- A01N1/143—Apparatus for organ perfusion
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/16—Physical preservation processes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P90/00—Enabling technologies with a potential contribution to greenhouse gas [GHG] emissions mitigation
- Y02P90/02—Total factory control, e.g. smart factories, flexible manufacturing systems [FMS] or integrated manufacturing systems [IMS]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Abstract
Description
技术领域Technical field
本发明涉及医疗领域,尤其是涉及一种器官灌注控制方法、系统以及装置。The present invention relates to the medical field, and in particular, to an organ perfusion control method, system and device.
背景技术Background technique
器官移植是指将有活力的供体器官通过手术转移至患者体内,以替代已经丧失功能的器官。目前,人体内大部分器官已能实现移植,如心脏、肺、肝、肾脏、胰、小肠等。此外,角膜和血管等组织的移植也已经非常成熟。离体器官保存主要分为静态冷保存与机械灌注两种技术路径。静态冷保存容易造成再灌注损伤,影响器官移植手术的效果。Organ transplantation refers to the surgical transfer of viable donor organs into the patient's body to replace organs that have lost function. Currently, most organs in the human body can be transplanted, such as the heart, lungs, liver, kidneys, pancreas, small intestine, etc. In addition, transplantation of tissues such as cornea and blood vessels is also very mature. Ex vivo organ preservation is mainly divided into two technical approaches: static cold preservation and mechanical perfusion. Static cold storage can easily cause reperfusion injury and affect the effectiveness of organ transplantation.
而采用机械灌注技术,离体器官可获得模拟生理参数的环境,通过灌流液获取氧气和营养成分等,维持正常的代谢功能。Using mechanical perfusion technology, isolated organs can obtain an environment that simulates physiological parameters, obtain oxygen and nutrients through the perfusion fluid, and maintain normal metabolic functions.
目前大多数的肝脏灌注系统采用双路离心泵对肝动脉和门静脉分别进行灌注,通过不同的控制系统对两个回路进行独立调控,但是由于离心泵价格较贵,且泵头为一次性耗材,单次灌注成本较高。另外现有的对离心泵的控制方法,调节时间长,鲁棒性差。At present, most liver perfusion systems use dual-path centrifugal pumps to perfuse the hepatic artery and portal vein respectively, and independently regulate the two circuits through different control systems. However, because the centrifugal pump is more expensive and the pump head is a disposable consumable, The cost per injection is higher. In addition, the existing control methods for centrifugal pumps require long adjustment times and poor robustness.
发明内容Contents of the invention
为了克服现有技术的不足,本发明的目的之一在于提供一种采用一个离心泵对动脉和静脉进行灌注的器官灌注控制方法,成本低,并且鲁棒性强。In order to overcome the shortcomings of the prior art, one of the objects of the present invention is to provide an organ perfusion control method that uses a centrifugal pump to perfuse arteries and veins, which is low-cost and highly robust.
为了克服现有技术的不足,本发明的目的之二在于提供一种采用一个离心泵对动脉和静脉进行灌注的器官灌注控制系统,成本低,并且鲁棒性强。In order to overcome the shortcomings of the prior art, the second object of the present invention is to provide an organ perfusion control system that uses a centrifugal pump to perfuse arteries and veins, which is low-cost and highly robust.
为了克服现有技术的不足,本发明的目的之三在于提供一种采用一个离心泵对动脉和静脉进行灌注的器官灌注控制装置,成本低,并且鲁棒性强。In order to overcome the shortcomings of the prior art, the third object of the present invention is to provide an organ perfusion control device that uses a centrifugal pump to perfuse arteries and veins, which is low-cost and highly robust.
本发明的目的之一采用如下技术方案实现:One of the purposes of the present invention is achieved by adopting the following technical solutions:
一种器官灌注控制方法,包括以下步骤:An organ perfusion control method includes the following steps:
搭建器官灌注控制系统:一离心泵分别通过动脉管路以及静脉管路与器官连通,动脉管路上设有第一压力传感器,静脉管路上设有第二压力传感器以及第一流阻执行器,控制器与所述离心泵、所述第一压力传感器、所述第二压力传感器以及所述第一流阻执行器通信连接;Build an organ perfusion control system: a centrifugal pump is connected to the organ through the arterial pipeline and the venous pipeline respectively. The arterial pipeline is equipped with a first pressure sensor, and the venous pipeline is equipped with a second pressure sensor and a first flow resistance actuator. The controller Communicatively connected to the centrifugal pump, the first pressure sensor, the second pressure sensor and the first flow resistance actuator;
离心泵产生搏动流:将所述第一压力传感器的平均压力反馈控制转速波形和实时压力反馈控制转速波形叠加,使所述离心泵产生搏动性灌注流,模拟人体真实动脉供血压力波动;The centrifugal pump generates a pulsatile flow: superimposes the average pressure feedback control speed waveform of the first pressure sensor and the real-time pressure feedback control speed waveform, so that the centrifugal pump generates a pulsatile perfusion flow, simulating the real arterial blood supply pressure fluctuation of the human body;
动脉搏动式灌注:将搏动性灌注流灌注到器官动脉;Arterial pulsatile perfusion: Perfusing a pulsatile perfusion flow into organ arteries;
静脉稳定压力灌注:以所述第二压力传感器的实时压力作为反馈,建立双路灌注耦合模型,根据离心泵产生的搏动流,以模糊神经网络方法进行解耦调控,反向调节流阻执行器,搏动流通过流阻执行器变为稳定压力灌注,灌注到器官静脉。Stable venous pressure perfusion: Using the real-time pressure of the second pressure sensor as feedback, a dual-channel perfusion coupling model is established. Based on the pulsating flow generated by the centrifugal pump, the fuzzy neural network method is used for decoupling control and the flow resistance actuator is reversely adjusted. , the pulsatile flow changes to stable pressure perfusion through the flow resistance actuator, and is perfused into the organ veins.
进一步的,在离心泵产生搏动流步骤中,将所述第一压力传感器的平均压力反馈控制离心血泵转速波形和实时压力反馈控制离心血泵控制波形叠加具体为:采用搏动脉冲发生器生成搏动脉冲转速,采用模糊神经网络控制器输出稳定泵转速,将搏动脉冲转速与稳定泵转速合成并输出到离心泵。Further, in the centrifugal pump generating pulsating flow step, superimposing the average pressure feedback control centrifugal blood pump speed waveform of the first pressure sensor and the real-time pressure feedback control centrifugal blood pump control waveform is as follows: using a pulsation pulse generator to generate pulsation For the pulse speed, the fuzzy neural network controller is used to output the stable pump speed, and the pulsating pulse speed and the stable pump speed are synthesized and output to the centrifugal pump.
进一步的,所述采用搏动脉冲发生器生成搏动脉冲转速具体为:根据所述第一压力传感器反馈的实时压力值,所述搏动脉冲发生器生成周期性搏动脉冲转速ωp。Further, the use of the pulsation pulse generator to generate the pulsation pulse rotation speed is specifically: based on the real-time pressure value fed back by the first pressure sensor, the pulsation pulse generator generates a periodic pulsation pulse rotation speed ω p .
进一步的,所述采用模糊神经网络控制器输出稳定泵转速具体为:所述控制器根据目标压力,产生初始离心泵转速,所述第一压力传感器反馈搏动周期内平均压力,通过模糊神经网络控制器输出离心泵转速ωm。Further, the use of a fuzzy neural network controller to output a stable pump speed is specifically: the controller generates an initial centrifugal pump speed according to the target pressure, and the first pressure sensor feeds back the average pressure within the pulsation cycle, which is controlled by the fuzzy neural network. The device outputs the centrifugal pump speed ω m .
进一步的,所述通过模糊神经网络控制器输出离心泵转速ωm具体为:以压力误差和压力误差变化率作为模糊神经网络的输入变量,经过网络的模糊推理输出三个参数Kp,Ki,Kd给PID控制器,再通过PID控制器的历史调节数据进行学习训练,自动调整加权系统,输出稳定控制的PID参数,PID控制器输出实时控制转速ωm。Further, the output of the centrifugal pump speed ω m through the fuzzy neural network controller is specifically: using the pressure error and the pressure error change rate as input variables of the fuzzy neural network, and outputting three parameters Kp, Ki, Kd through fuzzy reasoning of the network Give the PID controller, and then conduct learning and training through the historical adjustment data of the PID controller, automatically adjust the weighting system, and output the PID parameters for stable control. The PID controller outputs the real-time control speed ω m .
进一步的,所述静脉稳定压力灌注步骤具体为:所述控制器根据目标压力,产生第一流阻执行器初始流阻,第二压力传感器实时反馈实时压力值,以压力误差和压力误差变化率作为模糊神经网络的输入变量,经过网络的模糊推理输出三个参数Kp,Ki,Kd给PID控制器,再通过PID控制器的历史调节数据进行学习训练,自动调整加权系统,输出稳定控制的PID参数,PID控制器输出实时控制流阻,通过第一流阻执行器调整实时流阻。Further, the stable venous pressure perfusion step is specifically: the controller generates the initial flow resistance of the first flow resistance actuator according to the target pressure, and the second pressure sensor feeds back the real-time pressure value in real time, using the pressure error and the pressure error change rate as The input variables of the fuzzy neural network output three parameters Kp, Ki, Kd to the PID controller through fuzzy reasoning of the network, and then conduct learning and training through the historical adjustment data of the PID controller, automatically adjust the weighting system, and output the PID parameters for stable control. , the PID controller output controls the flow resistance in real time, and the real-time flow resistance is adjusted through the first flow resistance actuator.
进一步的,所述静脉稳定压力灌注步骤还包括:在静脉管路设置压力波动缓冲单元,压力波动缓冲单元为具有存储功能的容器,所述压力波动缓冲单元根据第二压力传感器实时反馈实时压力值存储灌注液。Further, the stable venous pressure perfusion step also includes: setting a pressure fluctuation buffer unit in the venous pipeline. The pressure fluctuation buffer unit is a container with a storage function. The pressure fluctuation buffer unit feeds back the real-time pressure value in real time according to the second pressure sensor. Store perfusate.
进一步的,在所述搭建器官灌注控制系统步骤中,动脉管路上还设有第一流量传感器,所述第一流量传感器采集动脉管路的实时流量;所述静脉管路上还设有第二流量传感器,所述第二流量传感器采集静脉管路的实时流量。Further, in the step of building the organ perfusion control system, a first flow sensor is also provided on the arterial pipeline, and the first flow sensor collects the real-time flow rate of the arterial pipeline; a second flow sensor is also provided on the venous pipeline. Sensor, the second flow sensor collects the real-time flow rate of the venous pipeline.
进一步的,在所述搭建器官灌注控制系统步骤中,器官通过下腔静脉与储存器连通,下腔静脉设有第二流阻执行器,所述第二流阻执行器与所述控制器通信连接,所述第二流阻执行器调节所述下腔静脉的压力并调节动脉管路和静脉管路内的流量比,所述储存器通过离心泵与所述动脉管路以及静脉管路连通实现循环。Further, in the step of building the organ perfusion control system, the organ is connected to the reservoir through the inferior vena cava, and the inferior vena cava is provided with a second flow resistance actuator, and the second flow resistance actuator communicates with the controller. connected, the second flow resistance actuator adjusts the pressure of the inferior vena cava and adjusts the flow ratio in the arterial line and the venous line, and the reservoir is connected to the arterial line and the venous line through a centrifugal pump Realize the cycle.
本发明的目的之二采用如下技术方案实现:The second object of the present invention is achieved by adopting the following technical solutions:
一种器官灌注控制系统,用于实施上述任意一种所述的器官灌注控制方法。An organ perfusion control system is used to implement any one of the above organ perfusion control methods.
本发明的目的之三采用如下技术方案实现:The third object of the present invention is achieved by adopting the following technical solutions:
一种器官灌注控制装置,包括离心泵、动脉管路以及静脉管路,所述离心泵同时与所述动脉管路以及所述静脉管路连通,所述动脉管路以及所述静脉管与器官连通,所述动脉管路上设有第一压力传感器,所述静脉管路上设有第二压力传感器,所述器官灌注控制装置还包括处理器以及储存器,所述储存器与所述处理器通信连接;所述储存器存储有可被所述处理器执行的指令,所述指令被所述处理器执行以实现上述任意一种所述的器官灌注控制方法。An organ perfusion control device includes a centrifugal pump, an arterial pipeline and a venous pipeline. The centrifugal pump is connected to the arterial pipeline and the venous pipeline at the same time. The arterial pipeline and the venous pipeline are connected to the organ. Communicated, the arterial pipeline is provided with a first pressure sensor, the venous pipeline is provided with a second pressure sensor, the organ perfusion control device also includes a processor and a storage, the storage communicates with the processor Connection; the storage stores instructions that can be executed by the processor, and the instructions are executed by the processor to implement any one of the above organ perfusion control methods.
相比现有技术,本发明器官灌注控制方法中采用一个离心泵,节约成本,体积更小,耗材成本低,经济效益高;离心泵分别通过动脉管路以及静脉管路与器官连通进行灌注,动脉管路上设有第一压力传感器,静脉管路上设有第二压力传感器以及流阻执行器,通过离心泵产生搏动流,动脉搏动式灌注,降低溶血风险;静脉稳定压力灌注,提供了一种类人体生理参数的环境,对于离体肝脏的保存和修复提供大大的益处。Compared with the prior art, the organ perfusion control method of the present invention uses a centrifugal pump, which saves costs, is smaller, has low consumable costs, and has high economic benefits; the centrifugal pump is connected to the organ through arterial pipelines and venous pipelines to perform perfusion. There is a first pressure sensor on the arterial line, and a second pressure sensor and a flow resistance actuator on the venous line. The centrifugal pump generates pulsating flow and arterial pulsating perfusion reduces the risk of hemolysis; venous stable pressure perfusion provides a kind of The environment of human physiological parameters provides great benefits to the preservation and repair of isolated liver.
附图说明Description of the drawings
图1为本发明器官灌注控制系统的结构示意图;Figure 1 is a schematic structural diagram of the organ perfusion control system of the present invention;
图2为本发明器官灌注控制系统的肝动脉搏动灌注控制原理示意图;Figure 2 is a schematic diagram of the hepatic artery pulse perfusion control principle of the organ perfusion control system of the present invention;
图3为模糊神经网络控制器原理示意图;Figure 3 is a schematic diagram of the fuzzy neural network controller principle;
图4为静脉控制原理示意图;Figure 4 is a schematic diagram of the vein control principle;
图5为动脉搏动式灌注压力图;Figure 5 is an arterial pulsatile perfusion pressure diagram;
图6为静脉稳定压力灌注压力图。Figure 6 is a graph of venous stable pressure perfusion pressure.
具体实施方式Detailed ways
下面将结合本发明实施例中的附图,对本发明实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例仅仅是本发明一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例,都属于本发明保护的范围。The technical solutions in the embodiments of the present invention will be clearly and completely described below with reference to the accompanying drawings in the embodiments of the present invention. Obviously, the described embodiments are only some of the embodiments of the present invention, rather than all the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by those of ordinary skill in the art without creative efforts fall within the scope of protection of the present invention.
需要说明的是,当组件被称为“固定于”另一个组件,它可以直接在另一个组件上或者也可以存在另一中间组件,通过中间组件固定。当一个组件被认为是“连接”另一个组件,它可以是直接连接到另一个组件或者可能同时存在另一中间组件。当一个组件被认为是“设置于”另一个组件,它可以是直接设置在另一个组件上或者可能同时存在另一中间组件。本文所使用的术语“垂直的”、“水平的”、“左”、“右”以及类似的表述只是为了说明的目的。It should be noted that when a component is referred to as being "fixed to" another component, it can be directly on the other component or another intermediate component may be present through which it is fixed. When a component is said to be "connected" to another component, it can be directly connected to the other component or there may be another intermediate component present at the same time. When a component is said to be "disposed on" another component, it can be directly located on the other component or another intervening component may be present. The terms "vertical," "horizontal," "left," "right" and similar expressions are used herein for illustrative purposes only.
除非另有定义,本文所使用的所有的技术和科学术语与属于本发明的技术领域的技术人员通常理解的含义相同。本文中在本发明的说明书中所使用的术语只是为了描述具体的实施例的目的,不是旨在于限制本发明。本文所使用的术语“及/或”包括一个或多个相关的所列项目的任意的和所有的组合。Unless otherwise defined, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the technical field to which the invention belongs. The terminology used herein in the description of the invention is for the purpose of describing specific embodiments only and is not intended to limit the invention. As used herein, the term "and/or" includes any and all combinations of one or more of the associated listed items.
请参阅图1至图4,为器官灌注控制方法,包括以下步骤:Please refer to Figure 1 to Figure 4 for the organ perfusion control method, which includes the following steps:
搭建器官灌注控制系统:一离心泵分别通过动脉管路以及静脉管路与器官连通,动脉管路上设有第一压力传感器,静脉管路上设有第二压力传感器以及流阻执行器,控制器与所述离心泵、所述第一压力传感器、所述第二压力传感器以及所述流阻执行器通信连接;Build an organ perfusion control system: a centrifugal pump is connected to the organ through the arterial pipeline and the venous pipeline respectively. The arterial pipeline is equipped with a first pressure sensor, and the venous pipeline is equipped with a second pressure sensor and a flow resistance actuator. The controller and The centrifugal pump, the first pressure sensor, the second pressure sensor and the flow resistance actuator are communicatively connected;
离心泵产生搏动流:将所述第一压力传感器的平均压力反馈控制转速波形和实时压力反馈控制转速波形叠加,使所述离心泵产生搏动性灌注流,模拟人体真实动脉供血压力波动;The centrifugal pump generates a pulsatile flow: superimposes the average pressure feedback control speed waveform of the first pressure sensor and the real-time pressure feedback control speed waveform, so that the centrifugal pump generates a pulsatile perfusion flow, simulating the real arterial blood supply pressure fluctuation of the human body;
动脉搏动式灌注:将搏动性灌注流灌注到器官动脉;Arterial pulsatile perfusion: Perfusing a pulsatile perfusion flow into organ arteries;
静脉稳定压力灌注:以所述第二压力传感器的实时压力作为反馈,建立双路灌注耦合模型,根据离心泵产生的搏动流,以模糊神经网络方法进行解耦调控,反向调节第一流阻执行器,搏动流通过第一流阻执行器变为稳定压力灌注,灌注到器官静脉。Stable venous pressure perfusion: Using the real-time pressure of the second pressure sensor as feedback, a dual-channel perfusion coupling model is established. According to the pulsating flow generated by the centrifugal pump, the fuzzy neural network method is used for decoupling control, and the first flow resistance is reversely adjusted to execute device, the pulsating flow changes into stable pressure perfusion through the first flow resistance actuator, and is perfused into the organ veins.
搭建器官灌注控制系统步骤具体为:The specific steps to build an organ perfusion control system are:
器官灌注控制系统还包括第一流量传感器、第二流量传感器、第二流阻执行器以及储存器,离心泵通过高速运转泵头带动灌注液在整个回路中进行循环运转,第一压力传感器采集动脉回路的实时压力值,第一流量传感器采集动脉回路的实时流量值,第二压力传感器采集静脉回路的实时压力值,第二流量传感器采集静脉回路的实时流量值,流阻执行器调节静脉回路流阻值。在本申请中,离心泵的数量为一个,一个离心泵同时与动脉回路以及静脉回路连通,节约成本,体积更小,耗材成本低,经济效益高。储存器用于存储灌注液,储存器内部还设有透析组件,以便于灌注液透析后循环利用。器官灌注控制系统还设有下腔静脉,下腔静脉与储存器连通,储存器与离心泵连通。在本实施例中,器官为肝脏。第二流阻执行器有两个作用,由于储存器为空心容器,灌注流经由动脉和静脉双路灌注到器官后,出口处压力过低,易导致系统内压力波动过大,增加第二流阻执行器,调节其流阻,可有效改善系统内压力剧烈波动;通过第二流阻执行器,可以调节动脉和静脉内的流量比,流量可通过第一流量传感器、第二流量传感器获得,使得两管路中的流量更接近于人体内真实环境。The organ perfusion control system also includes a first flow sensor, a second flow sensor, a second flow resistance actuator and a storage device. The centrifugal pump drives the perfusion fluid to circulate throughout the entire circuit by operating the pump head at high speed. The first pressure sensor collects arterial data. The first flow sensor collects the real-time flow value of the arterial circuit, the second pressure sensor collects the real-time pressure value of the venous circuit, the second flow sensor collects the real-time flow value of the venous circuit, and the flow resistance actuator adjusts the venous circuit flow resistance value. In this application, the number of centrifugal pumps is one, and one centrifugal pump is connected to the arterial circuit and the venous circuit at the same time, saving costs, smaller volume, low consumable costs, and high economic benefits. The reservoir is used to store the perfusate, and a dialysis component is also provided inside the reservoir to facilitate the recycling of the perfusate after dialysis. The organ perfusion control system is also equipped with an inferior vena cava, which is connected to the reservoir, and the reservoir is connected to the centrifugal pump. In this example, the organ is the liver. The second flow resistance actuator has two functions. Since the reservoir is a hollow container, after the perfusion flow is perfused to the organ through both arteries and veins, the pressure at the outlet is too low, which can easily lead to excessive pressure fluctuations in the system and increase the second flow rate. The flow resistance of the flow resistance actuator can be adjusted to effectively improve the violent pressure fluctuations in the system; the flow ratio of the artery and the vein can be adjusted through the second flow resistance actuator, and the flow rate can be obtained through the first flow sensor and the second flow sensor. This makes the flow rate in the two pipelines closer to the real environment in the human body.
离心泵产生搏动流步骤具体为:The specific steps for a centrifugal pump to generate pulsating flow are:
控制器根据目标压力,产生初始离心泵转速,第一压力传感器反馈搏动周期(1Hz)内平均压力,通过模糊神经网络控制器输出离心泵转速ωm。另外,搏动脉冲发生器,根据第一压力传感器反馈的实时压力值,生成周期性搏动脉冲转速ωp,两个转速值合成后,输出给离心泵,产生搏动性灌注流,降低溶血风险。模糊神经网络控制器原理示意图如图3所示,控制器根据目标压力生成初始离心泵转速,以压力误差和压力误差变化率作为模糊神经网络的输入变量,经过网络的模糊推理输出三个参数Kp,Ki,Kd给PID控制器,再通过PID控制器的历史调节数据进行学习训练,自动调整加权系统,输出稳定控制的PID参数。PID控制器输出实时控制转速,控制离心泵调整转速。The controller generates the initial centrifugal pump speed according to the target pressure, the first pressure sensor feeds back the average pressure within the pulsation period (1Hz), and outputs the centrifugal pump speed ω m through the fuzzy neural network controller. In addition, the pulsating pulse generator generates a periodic pulsating pulse rotation speed ω p based on the real-time pressure value fed back by the first pressure sensor. After the two rotational speed values are synthesized, they are output to the centrifugal pump to generate a pulsatile perfusion flow and reduce the risk of hemolysis. The schematic diagram of the fuzzy neural network controller principle is shown in Figure 3. The controller generates the initial centrifugal pump speed according to the target pressure, uses the pressure error and the pressure error change rate as the input variables of the fuzzy neural network, and outputs three parameters Kp through fuzzy reasoning of the network , Ki, Kd are given to the PID controller, and then the historical adjustment data of the PID controller are used for learning and training, the weighting system is automatically adjusted, and the PID parameters for stable control are output. The output of the PID controller controls the speed in real time and controls the centrifugal pump to adjust the speed.
静脉稳定压力灌注步骤具体为:The specific steps for stable intravenous pressure perfusion are:
门静脉灌注需要维持稳定的压力,如图4所示,其具体实施方式为,控制器根据目标压力,产生流阻执行器初始流阻,第二压力传感器实时反馈实时压力值,以压力误差和压力误差变化率作为模糊神经网络的输入变量,经过网络的模糊推理输出三个参数Kp,Ki,Kd给PID控制器,再通过PID控制器的历史调节数据进行学习训练,自动调整加权系统,输出稳定控制的PID参数。PID控制器输出实时控制流阻,通过流阻执行器调整实时流阻。Portal vein perfusion needs to maintain a stable pressure, as shown in Figure 4. The specific implementation method is that the controller generates the initial flow resistance of the flow resistance actuator according to the target pressure, and the second pressure sensor feeds back the real-time pressure value in real time to calculate the pressure error and pressure. The error change rate is used as the input variable of the fuzzy neural network. After the fuzzy reasoning of the network, the three parameters Kp, Ki, and Kd are output to the PID controller. Then, the historical adjustment data of the PID controller is used for learning and training, and the weighting system is automatically adjusted to achieve stable output. Control PID parameters. The PID controller output controls the flow resistance in real time, and the real-time flow resistance is adjusted through the flow resistance actuator.
在静脉稳定压力灌注步骤中,还可以再静脉回路上设置压力波动缓冲单元,压力波动缓冲单元为小型空心容器,具有存储功能,压力波动缓冲单元根据第二压力传感器实时反馈实时压力值存储灌注液。In the stable venous pressure perfusion step, a pressure fluctuation buffer unit can also be installed on the venous circuit. The pressure fluctuation buffer unit is a small hollow container with a storage function. The pressure fluctuation buffer unit stores the perfusion fluid according to the real-time pressure value fed back by the second pressure sensor in real time. .
本申请还涉及实施上述器官灌注控制方法的系统以及装置。The present application also relates to systems and devices for implementing the above organ perfusion control method.
本发明涉及的肝脏灌注控制方法,优化了机械灌注系统,提供了一种类人体生理参数的环境,对于离体肝脏的保存和修复提供大大的益处;单离心泵,节约成本,体积更小,耗材成本低,经济效益高;肝动脉搏动式灌注,将平均压力反馈控制离心血泵转速波形和实时压力反馈控制离心血泵控制波形叠加,控制方法创新,实现肝动脉搏动压力,模拟人体真实动脉供血压力波动,如图5所示。具体实施方式为,采用搏动脉冲发生器生成搏动脉冲转速,与模糊神经网络控制器输出的稳定血泵转速合成后,输出到离心血泵,调节离心血泵转速,达到肝动脉搏动式灌注,降低溶血风险;门静脉稳定压力灌注,以实时压力作为反馈,建立双路灌注耦合模型,根据肝动脉搏动,以模糊神经网络方法进行解耦调控,反向调节流阻执行器,达到门静脉稳定压力范围,如图6所示。采用模糊神经网络PID算法控制离心泵,以压力传感器搏动周期内平均压力值作为反馈,调节离心血泵转速,利用了模糊神经网络的学习和自适应能力,对于当前的非线性控制问题具有优势,鲁棒性更强。The liver perfusion control method involved in the present invention optimizes the mechanical perfusion system, provides an environment similar to human physiological parameters, and provides great benefits for the preservation and repair of isolated livers; a single centrifugal pump saves costs, is smaller, and requires less consumables. Low cost and high economic benefits; hepatic artery pulsatile perfusion superimposes the average pressure feedback control centrifugal blood pump speed waveform and the real-time pressure feedback control centrifugal blood pump control waveform. The control method is innovative to achieve hepatic artery pulsation pressure and simulate the real arterial blood supply of the human body. Pressure fluctuations, as shown in Figure 5. The specific implementation method is to use a pulsating pulse generator to generate a pulsating pulse speed, synthesize it with the stable blood pump speed output by the fuzzy neural network controller, and then output it to the centrifugal blood pump to adjust the centrifugal blood pump speed to achieve hepatic artery pulsatile perfusion and reduce Risk of hemolysis; portal vein stable pressure perfusion uses real-time pressure as feedback to establish a dual-channel perfusion coupling model. According to the hepatic artery pulse, the fuzzy neural network method is used for decoupling control, and the flow resistance actuator is reversely adjusted to achieve a stable portal vein pressure range. As shown in Figure 6. The fuzzy neural network PID algorithm is used to control the centrifugal pump, and the average pressure value within the pulse cycle of the pressure sensor is used as feedback to adjust the speed of the centrifugal blood pump. The learning and adaptive capabilities of the fuzzy neural network are used, which has advantages for current nonlinear control problems. More robust.
以上实施例仅表达了本发明的几种实施方式,其描述较为具体和详细,但并不能因此而理解为对发明专利范围的限制。应当指出的是,对于本领域的普通技术人员来说,在不脱离本发明构思的前提下,还可以做出若干变形和改进演变,都是依据本发明实质技术对以上实施例做的等同修饰与演变,这些都属于本发明的保护范围。The above embodiments only express several embodiments of the present invention, and their descriptions are relatively specific and detailed, but they should not be construed as limiting the scope of the invention. It should be noted that, for those of ordinary skill in the art, several modifications and improvements can be made without departing from the concept of the present invention, which are equivalent modifications to the above embodiments based on the essential technology of the present invention. and evolution, these all belong to the protection scope of the present invention.
Claims (6)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310171998.0A CN116235846B (en) | 2023-02-27 | 2023-02-27 | Organ perfusion control method, system and device |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310171998.0A CN116235846B (en) | 2023-02-27 | 2023-02-27 | Organ perfusion control method, system and device |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116235846A CN116235846A (en) | 2023-06-09 |
CN116235846B true CN116235846B (en) | 2024-01-30 |
Family
ID=86634683
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202310171998.0A Active CN116235846B (en) | 2023-02-27 | 2023-02-27 | Organ perfusion control method, system and device |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116235846B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN119366512A (en) * | 2024-12-27 | 2025-01-28 | 北京清瀚医疗科技有限公司 | A heartbeat simulation method and system for organ perfusion |
CN119376443A (en) * | 2024-12-27 | 2025-01-28 | 北京清瀚医疗科技有限公司 | A pressure control system for organ perfusion equipment |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105379707A (en) * | 2015-12-16 | 2016-03-09 | 浙江大学 | Liver normal temperature perfusion restoration system |
CN106659151A (en) * | 2014-06-02 | 2017-05-10 | 特兰斯迈迪茨公司 | Ex vivo organ care system |
CN107114358A (en) * | 2017-06-14 | 2017-09-01 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | liver perfusion control system, method and device |
CN108432743A (en) * | 2018-06-15 | 2018-08-24 | 广州军区广州总医院 | Portable organ contributes donor machine perfusion system |
CN109688811A (en) * | 2016-07-22 | 2019-04-26 | 苏黎世联邦理工学院 | Perfusion circuit assemblies and liver chamber combination in vitro liver perfusion |
CN113476737A (en) * | 2021-07-02 | 2021-10-08 | 中国科学院江西稀土研究院 | Method, device and storage medium for improving bionic pulsation of artificial heart pump blood flow |
CN114740728A (en) * | 2022-04-25 | 2022-07-12 | 哈尔滨工业大学 | Isolated heart perfusion blood pressure self-adaptive control method based on semi-parametric model |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11154049B2 (en) * | 2016-01-06 | 2021-10-26 | Washington University | Systems and methods for normothermic extracorporeal organ perfusion |
-
2023
- 2023-02-27 CN CN202310171998.0A patent/CN116235846B/en active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106659151A (en) * | 2014-06-02 | 2017-05-10 | 特兰斯迈迪茨公司 | Ex vivo organ care system |
CN105379707A (en) * | 2015-12-16 | 2016-03-09 | 浙江大学 | Liver normal temperature perfusion restoration system |
CN109688811A (en) * | 2016-07-22 | 2019-04-26 | 苏黎世联邦理工学院 | Perfusion circuit assemblies and liver chamber combination in vitro liver perfusion |
CN107114358A (en) * | 2017-06-14 | 2017-09-01 | 广东顺德工业设计研究院(广东顺德创新设计研究院) | liver perfusion control system, method and device |
CN108432743A (en) * | 2018-06-15 | 2018-08-24 | 广州军区广州总医院 | Portable organ contributes donor machine perfusion system |
CN113476737A (en) * | 2021-07-02 | 2021-10-08 | 中国科学院江西稀土研究院 | Method, device and storage medium for improving bionic pulsation of artificial heart pump blood flow |
CN114740728A (en) * | 2022-04-25 | 2022-07-12 | 哈尔滨工业大学 | Isolated heart perfusion blood pressure self-adaptive control method based on semi-parametric model |
Also Published As
Publication number | Publication date |
---|---|
CN116235846A (en) | 2023-06-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN116235846B (en) | Organ perfusion control method, system and device | |
US11963526B2 (en) | Apparatus and method for organ perfusion | |
Griffith et al. | HeartMate II left ventricular assist system: from concept to first clinical use | |
Frazier et al. | Optimization of axial-pump pressure sensitivity for a continuous-flow total artificial heart | |
Petrou et al. | A versatile hybrid mock circulation for hydraulic investigations of active and passive cardiovascular implants | |
CN107467011B (en) | Liver takes oxygen machinery perfusion device | |
Ng et al. | Application of adaptive starling-like controller to total artificial heart using dual rotary blood pumps | |
Fumoto et al. | In vivo acute performance of the Cleveland Clinic self-regulating, continuous-flow total artificial heart | |
CN113476737B (en) | Method, device and storage medium for improving bionic pulsatility of blood flow of artificial heart pump | |
CN107114358B (en) | liver machine perfusion control system, method and device | |
Shiose et al. | Speed modulation of the continuous-flow total artificial heart to simulate a physiologic arterial pressure waveform | |
Gao et al. | A pulsatile control algorithm of continuous-flow pump for heart recovery | |
Koh et al. | A centralized multi-objective model predictive control for a biventricular assist device: An in silico evaluation | |
Gao et al. | The hemodynamic effect of the support mode for the intra‐aorta pump on the cardiovascular system | |
Koh et al. | A centralized multi-objective model predictive control for a biventricular assist device: An in vitro evaluation | |
Khalil et al. | Induced pulsation of a continuous-flow total artificial heart in a mock circulatory system | |
Teman et al. | A novel rotary pulsatile flow pump for cardiopulmonary bypass | |
CN116650827A (en) | Flow Pulsatility Control System of ECMO Centrifugal Blood Pump Based on RBF Neural Network | |
Zhang et al. | The hemodynamic comparative study between pulsatile and non-pulsatile VA ECMO: A primary numerical study | |
Antaki et al. | Control of heart assist devices | |
Wu et al. | Numerical simulation for suction detection based on improved model of cardiovascular system | |
Tortora et al. | Experimental integration of Autoregulation Unit for left ventricular assist devices in a cardiovascular hybrid simulator | |
CN110313469A (en) | A kind of back loading device for Ex vivo heart perfusion | |
Huang et al. | Modeling of Accurately Predicting the Cavopulmonary Pressure Head in Fontan Blood Pump using Neural Network | |
An | Modeling and Analysis of Human Cardiovascular Dynamics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |